Display Settings:

Format

Send to:

Choose Destination
    Z Rheumatol. 2012 Jan;71(1):78-82.

    [Rheumatoid arthritis and multiple myeloma as comorbidity. Is tocilizumab a therapy option?].

    [Article in German]

    Source

    Klinik Innere Medizin IV (Rheumatologie, klinische Immunologie und Nephrologie), HSK, Dr.-Horst-Schmidt-Kliniken GmbH, Ludwig-Erhard-Str. 100, 65199, Wiesbaden, Deutschland. norbert.schuetz@hsk-wiesbaden.de

    Abstract

    Multiple myeloma (MM) is a disease of the elderly with an incidence of 4/100,000 per year and can occur as a comorbidity especially in elderly patients with rheumatoid arthritis (RA). For MM and also for RA interleukin-6 (IL-6) is a pathogenetically important cytokine in both disease events. This article presents the case of a female patient who achieved sustained remission of RA and stabilization of MM with quantitative reduction of paraprotein by treatment with tocilizumab. The question whether tocilizumab represents a meaningful treatment approach for treatment of RA when MM is also present will be discussed.

    PMID:
    22286359
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk